QLT Inc. (QLTI) Issues 12-Month Results from DENALI Study on verteporfin PDT; Trial Didn't Show Non-Inferior Gain
Tweet Send to a Friend
QLT Inc. (Nasdaq: QLTI) today announced that final results from the Novartis-sponsored Phase IIIb DENALI study were presented on June ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
